Proteomics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Hepatitis
Reports outline acute hepatitis study results from University of Ulm
June 15th, 2009
According to a study from Ulm, Germany, "Coinhibitors and costimulators control intrahepatic T cell responses that trigger acute hepatitis. We used the ConA-induced hepatitis model in the mouse to test if the coinhibitor herpes virus entry mediator (HVEM) modulates hepatitis-inducing T cell responses." "Compared with ConA-injected, wild-type (wt) C57BL/6 (116) mice, HVEM-deficient (HVEM-/-) B6 mice showed lower serum transaminase levels and lower proinflammatory IFN-gamma, but higher protective IL-22 serum levels and an attenuated liver histopathology. The liver type I invariant NKT cell population that initiates acute hepatitis in this model was reduced in HVEM-/- mice...
Source: Proteomics Weekly (2009-06-15)
|
